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(57) ABSTRACT 
A low-cost compact fiberless diffuse speckle contrast flow-
meter includes a small laser diode and a 2-dimensional 
imaging device such as a charge coupled device (CCD) or 
complementary metal oxide semiconductor (CMOS) for 
directly contacting the tissue and measuring a parameter 
such as blood flow in a deep/thick volume of tissue (up to 10 
mm depth). The small laser diode is fixed at a certain 
distance (0 to 20 mm) from the imaging device and directly 
contacts the tissue. Light emitted from the laser diode 
penetrates through the tissue and reflects back to the imaging 
device without passing through any lenses or fibers. One or 
more additional laser diodes may be added for producing 
light at different wavelengths, and the combination of mea-
surements taken by the imaging device at the different 
wavelengths allows for measuring additional parameters, 
such as both blood flow and blood oxygenation. 
22 Claims, 11 Drawing Sheets 
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COMPACT LOW-COST FIBERLESS DIFFUSE 
SPECKLE CONTRAST FLOW-OXIMETER 
This application claims priority to U.S. PROVISIONAL 
Application Ser. No. 62/365,119, filed Jul. 21, 2016, the 
disclosure of which is hereby incorporated by reference. 
TECHNICAL FIELD 
This invention generally relates to a device for noninva-
sively measuring tissue blood flow and oxygenation, and 
more particularly, to a compact fiberless diffuse speckle 
contrast flow-oximeter for measuring blood flow and oxy-
genation at relatively deep tissues below skin level. 
BACKGROUND OF THE INVENTION 
The measurements of blood flow (BF) and oxygenation 
alterations in the tissue helps characterize many diseases 
representing with tissue ischemia and hypoxia such as 
cerebral vascular disease, peripheral artery disease, and 
cancer. For example, more than 4 million babies are born 
annually in the United States and -11 % of those (440,000) 
are born premature and admitted to neonatal intensive care 
units (NICU s ). The total societal economic cost of preterm 
birth is estimated at 26 billion dollars including medical 
costs, early intervention, special education services, and lost 
household and labor market productivity. Although signifi-
cant progress has been made in the care of preterm infants, 
they continue to suffer from significant morbidities and 
comorbidities. Approximately 65% of infants born between 
25 and 28 weeks of gestational age (GA), and 85% of those 
born at GA of <24 weeks have patent ductus arteriosus 
(PDA) at first week of life. PDA leads to shunting of blood 
between the systemic and the pulmonary circulations, which 
2 
There have been a few recent technical advancements 
towards BF measurements in deep tissues with coherent NIR 
point-source illumination and high sensitive CCD detection 
(e.g., electron multiplication CCD (EMCCD)), where the 
5 diffuse speckle contrast spectroscopy/tomography extracts 
deep tissue BF information using the relationship between 
diffuse speckle contrast parameters and DCS/DCT theory. 
Hundreds of detectors provided by the CCD significantly 
improve the spatial and temporal resolution and reduce the 
10 instrumentation cost and dimension. In these measurement 
setups, a CCD sensor is generally connected with optical 
lenses or optical fibers to detect diffuse speckle contrast 
variations induced by the motion of red blood cells in the 
tissue (i.e., blood flow). A long-coherence length laser or a 
15 small laser diode are usually coupled to a lens system or an 
optical fiber to deliver NIR light to the target tissue. How-
ever, these noncontact (through optical lenses) or semi-
noncontact measurements (through optical lenses and opti-
cal fibers) with lasers and CCD cameras make the 
20 measurements very sensitive to motion artifacts and ambient 
light. In addition, EMCCDs and long-coherence length 
lasers used are still quite expensive and large. 
There are very few tools available for continual bedside 
assessment of neonatal brain health, which can be impacted 
25 by the PDA and associated treatment procedures. Transcra-
nial Doppler (TCD) probe is the commonly used bedside 
method to evaluate cerebral blood flow velocity (CBFV) in 
large arteries, but this method is difficult to perform con-
tinuously on neonatal heads and may not agree with CBF in 
30 local cerebral microvasculature. Near-infrared spectroscopy 
(NIRS) provides a continuous measurement of tissue oxy-
genation saturation (StO2 ) in local cerebral microvascula-
ture. However, there is a critical need for more evidence 
concerning sensitivities and accuracies before applying 
35 these measurements to clinical practice. A more recently 
developed method of near-infrared DCS provides a direct 
cerebral blood flow (CBF) measurement in local cerebral 
microvasculature. DCS monitors temporal speckle fluctua-
tions resulting from moving red blood cells (RBCs) and has 
is associated with adverse outcomes including prolonged 
assisted ventilation and higher rates of death, bronchopul-
monary dysplasia, pulmonary hemorrhage, necrotizing 
enterocolitis, impaired renal function, intraventricular hem-
orrhage, periventricular leukomalacia, and cerebral palsy. 
Because of these associated complications, the majority of 
infants at GA of s28 weeks receive medical or surgical 
therapy in an attempt to close the PDA. Currently, the gold 
standard for PDA diagnosis is echocardiography, but often 
clinical symptoms are not associated with echocardiography 45 
findings. 
40 proven to be a valid assessment of CBF variations in the 
brains of adults and children. DCS has been combined with 
NIRS into hybrid instruments for simultaneous measure-
ments of StO2 and CBF, which allows for the derivation of 
cerebral metabolic rate of oxygen (CMRO2 ). For example, 
a hybrid NIRS/DCS instrument was used to longitudinally 
obtain data from premature neonates' brains and results 
showed a steady decrease in StO2 and steady increases in 
CBF and CMRO2 during the first six weeks oflife, which are 
in qualitative agreement with physiological expectations. 
Also, in an animal model of neonatal brain injury, it has been 
shown that CMRO2 , and not StO2 , correlated with the 
duration of cerebral ischemia. These results suggest that 
multiple hemodynamic/metabolic variables provide more 
comprehensive assessment of neonatal brain health than a 
single parameter alone. However, as with blood flow mea-
surements, the use of DCS in measuring other parameters 
retains the shortcomings noted above. 
Compared to large imaging modalities such as computed 
tomography (CT), magnetic resonance imaging (MRI), and 
positron emission tomography (PET) for BF measurements, 
optical instruments are relatively portable, fast, continuous, 50 
and inexpensive. Optical techniques based on dynamic light 
scattering are the most common methods for BF measure-
ments including laser speckle contrast imaging (LSCI) and 
diffuse correlation spectroscopy/tomography (DCS/DCT). 
Each technique, however, has key issues that limit its 55 
application. LSCI uses wide-field illumination and charge-
coupled-device (CCD) detection of spatial laser speckle 
contrasts to achieve rapid high-resolution 2-D mapping of 
blood flow in superficial tissues ( depth <l mm). By contrast. 
DCS/DCT uses coherent near-infrared (NIR) point-source 60 
illumination and single-photon-counting avalanche photo-
diodes (APDs) to accommodate spectroscopic or tomo-
graphic measurements of BF variations in deep tissues (up 
to -15 mm). However, the use of expensive long-coherence 
length lasers (e.g. DL785-120, Crystalaser) andAPDs (e.g. 65 
SPCM-NIR, Pacer) limits its spatial-temporal resolution and 
increases instrumentation cost. 
Accordingly, a need has been identified for a system for 
measuring multiple hemodynamic/metabolic variables, such 
as blood flow and blood oxygenation measurements in deep 
tissues, including through the skull, which addresses these 
and other shortcomings of current technologies. 
SUMMARY OF THE INVENTION 
An object of the disclosure is to provide a probe for use 
in measuring a hemodynamic parameter within a tissue of a 
US 10,842,422 B2 
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subject. For example, the hemodynamic parameter may be 
blood flow and/or blood oxygenation through the tissue. The 
probe may include a laser diode for emitting light into the 
tissue of the subject, and a bare imaging device adapted to 
contact the tissue of the subject and receive light reflected 5 
from the tissue to detect diffuse speckle contrast variations 
in the tissue for measurement of the hemodynamic param-
eter. The bare imaging device may be a 2-dimensional array 
imaging device. 
In one aspect, the probe may include no optical fiber. This 10 
may include no optical fiber associated with the laser diode 
or the bare imaging device. 
The laser diode may emit near-infrared light at a fixed 
wavelength. This fixed wavelength may range from 700-900 
15 
nm for the measurement of blood flow. For example, the 
wavelength may be 785 nm. The laser diode may produce a 
short coherence length through human tissue. For example, 
the coherence length of the laser diode may be 10 cm-100 
cm. The laser diode may be adapted to contact the tissue of 20 
the subject. 
In a further aspect, the probe may include a retainer for 
retaining the laser diode and the bare imaging device at fixed 
positions relative to each other. For example, the laser diode 
and the bare imaging device may be fixed relative to one 25 
another at a distance of between O and 20 mm. In one 
embodiment, this distance may be between 13 mm and 18 
mm. The retainer may comprise a pad, such as a foam pad, 
4 
subject, and may be further adapted to maintain the bare 
imaging device in contact with the tissue with no lens 
there between. 
In one aspect, the probe includes no optical fiber. 
The bare imaging device may comprise a charge coupled 
device. In another aspect, the bare imaging device may 
comprise a complementary metal oxide semiconductor. 
One or more heat sinks may be provided to assist in 
dissipating heat produced by the bare imaging device. For 
instance, one or more heat sinks may be in contact with the 
bare imaging device. In another aspect, a fan may be 
included for heat dissipation with respect to the bare imag-
ing device. In another aspect, a low-power imaging device 
may be included without the need of heat dissipation. 
In a further embodiment, a method is disclosed for 
measuring at least one hemodynamic parameter within a 
tissue of a subject. The method may include emitting light at 
a first wavelength from a first laser diode into the tissue 
without fiber coupling, said light not received through an 
optical cable, placing a bare imaging device in contact with 
the tissue with no lens therebetween, and measuring 
reflected light from the tissue to detect diffuse speckle 
contrast variations in the tissue in order to measure the at 
least one hemodynamic parameter. The first laser diode may 
produce a short coherence length (e.g. 10 cm-100 cm) when 
said light is emitted directly without fiber coupling through 
the tissue. 
In one aspect, the method may further include the step of or a plate. The retainer may include one or more receivers, 
such as holes, apertures, or recesses, for retaining the laser 
diode and the bare imaging device. 
The bare imaging device may be adapted to receive the 
light diffused and reflected from the tissue without passing 
through any lenses prior to receiving the light. Accordingly, 
the imaging device may be considered "bare," as it may 
contact the tissue of the subject. 
30 emitting light at a second wavelength from a second laser 
diode into the tissue. In this aspect, the measuring step may 
comprise measuring reflected lights from the tissue from the 
first laser diode and the second laser diode. 
In a further aspect, the method may include the step of 
35 attaching each of the first laser diode and the bare imaging 
device to a retainer in order to maintain a fixed distance 
there between. In the instance of the inclusion of the second 
laser diode, the method may include attaching the second 
The probe may further include or be adapted to connect 
with a controller for controlling the function of the bare 
imaging device. The controller may be remote from the bare 
imaging device. For example, in the case of the use of a 40 
retainer, the controller may not be in contact with the 
retainer. In one aspect, the controller may be connected to 
the bare imaging device via electrical wires. In another 
aspect, the controller may be wirelessly connected to the 
bare imaging. The controller may comprise a computer, a 45 
laptop, or other mobile device. 
The bare imaging device may comprise a charge coupled 
device. In another aspect, the bare imaging device may 
comprise a complementary metal oxide semiconductor. In 
one aspect, one or more heat sinks and/or a fan may be 50 
connected to the bare imaging device for dissipation of heat. 
In another embodiment, a probe is disclosed for use in 
measuring at least one hemodynamic parameter within a 
tissue of a subject. The probe may comprise a first laser 
diode adapted for emitting light into the tissue of the subject 55 
at a first wavelength, and a second laser diode adapted for 
emitting light into the tissue of the subject at a second 
wavelength different from the first wavelength. The probe 
may further include a bare imaging device adapted to 
contact the tissue of the subject and receive light diffused 60 
and reflected from the tissue to detect diffuse speckle con-
trast variations in the tissue for measurement of the at least 
one hemodynamic parameter. The probe may additionally 
include a retainer adapted to receive and maintain a constant 
distance from each of the first laser diode and the second 65 
laser diode to the bare imaging device, said retainer includ-
ing a contact surface adapted to contact the tissue of the 
laser diode to the retainer in order to maintain a fixed 
distance between the second laser diode and the bare imag-
ing device. The fixed distance from the first laser diode 
(and/or from the second laser diode) to the bare imaging 
device may be between O and 20 mm, or more narrowly, 
between 13 mm and 18 mm. 
BRIEF DESCRIPTION OF THE DRAWINGS 
FIG. 1 is a schematic of a contact diffuse speckle contrast 
flowmeter (DSCF) probe; 
FIG. 2 illustrates an imaging device of the DSCF of FIG. 
1; 
FIG. 3 is a schematic of a validity test of the imaging 
device of the DSCF probe of FIG. 1 in a tissue-simulating 
phantom, as compared to a contact diffuse correlation spec-
troscopy (DCS) probe and a non-contact imaging device 
probe; 
FIG. 4 is a schematic of a first dual contact probe used in 
the validity test of FIG. 3; 
FIGS. Sa-Sc are Bland-Altman plots illustrating the 
results of the validity test in a tissue-simulating phantom of 
FIG. 3; 
FIG. 6 is a schematic of a validity test of a laser diode of 
the DSCF of FIG. 1 in a tissue-simulating phantom; 
FIG. 7 is a schematic of a second dual contact probe used 
in the validity test of FIG. 6; 
FIGS. Sa-Sc are Bland-Altman plots illustrating the 
results of the validity test of FIG. 6; 
US 10,842,422 B2 
5 
FIG. 9 is a forearm of a subject with a third dual contact 
probe testing the validity of the laser diode with the imaging 
device of the DSCF of FIG. 1; 
FIG. 10 is a schematic of the third dual contact probe of 
FIG. 9; 
FIG. lla is a plot of the time course ofrelative blood flow 
data measured concurrently by the imaging device of the 
DSCF and a DCS probe in the forearm before, during, and 
after the occlusion; 
6 
wavelengths of 785 nm and 854 nm for measuring oxygen-
ation). More laser diodes (>2) can be used to improve 
measurement accuracy. The laser diode 12 may have a short 
coherence length. 
In one aspect, the bare imaging device 14 may comprise 
a sensor, a chip, or a combination of the two. For instance, 
the bare imaging device 14 may comprise a bare imaging 
chip 20 (which may be a CCD chip or a CMOS chip), 
FIG. llb is a Bland-Altman plot illustrating the results of 10 
the validity test of FIG. 9; 
including a bare imaging sensor 22 (which may be a CCD 
sensor or a CMOS sensor), approximately 40x32 mm2 , with 
a resolution of 1296x964 pixels. In a further aspect, the 
FIG. 12 is a schematic of a third dual contact probe for 
testing the validity of a low-power complementary metal 
oxide semiconductor (CMOS) based imaging device of a 
DSCF; 
FIG. 13a is a plot of the time course ofrelative blood flow 
data measured concurrently by the CMOS based imaging 
device of FIG. 12 and a DCS probe in the forearm before, 
during, and after occlusion; 
imaging device 14 may include no lenses. The lack oflenses 
indicates that the bare imaging device 14, including the bare 
imaging sensor chip 20, may be directly placed on the tissue 
15 surface S for contact measurements of BF variations in deep 
tissues ( e.g. approximately up to 10 mm below tissue 
surface, such as for example, 8 mm below tissue surface). In 
other words, the bare imaging device may be described as a 
FIG. 13b is a plot of the relative blood flows of the DCS 20 
probe against the CMOS based imaging device of FIG. 12; 
FIG. 14 illustrates the use of a DCS probe and a DSCF 
probe on an infant skull with a filled tissue-simulating liquid 
phantom; 
contact sensor because it may contact the tissue through 
which BF is measured. 
One embodiment of the DSCF probe 10 is illustrated in 
FIG. 1. As illustrated, the DSCF probe 10 may be placed on 
the surface S of turbid media M (e.g., tissue phantoms or 
human tissues) for flow measurements. The laser diode 12 
may act as a light source, and may be placed a known 
distance away from the bare imaging device 14. For 
FIG. 15a is a plot of the relative flow changes as measured 25 
by the DSCF probe against those as measured by the DCS 
probe as calculated by a linear algorithm; example, the laser diode 12 may be placed at a known 
distance away from an imaging sensor 22 ( e.g. a CCD sensor 
or CMOS sensor) of the bare imaging device 14. As illus-
trated, this distance may be between X 1 and X2 . This 
distance may be referred to as the source-detector (S-D) 
FIG. 15b is a plot of the relative flow changes as measured 
by the DSCF probe against those as measured by the DCS 
probe with a S-D distance of 15 mm as calculated by 30 
conventional semi-infinite solutions; 
FIG. 15c is a plot of the relative flow changes as measured 
by the DSCF probe against those as measured by the DCS 
probe with a S-D distance of 10 mm as calculated by 
conventional semi-infinite solutions; 
FIG. 16 is a schematic of a contact dual-wavelength 
diffuse speckle contrast flow-oximeter (DSCFO); and 
FIG. 17 illustrates the use of the dual-wavelength DSCFO 
of FIG. 16 on an infant cranium. 
DETAILED DESCRIPTION OF THE 
INVENTION 
The description provided below and in regard to the 
figures applies to all embodiments unless noted otherwise, 
and features common to each embodiment are similarly 
shown and numbered. 
In one aspect, the current disclosure identifies a low-cost 
compact fiberless diffuse speckle contrast flowmeter 
(DSCF) in order to measure blood flow. The DSCF may 
comprise a probe 10 including a laser diode 12 and a bare 
imaging device 14. This bare imaging device 14 may 
comprise a 2-dimensional array imaging device. For 
example, the bare imaging device 14 may comprise a 
charge-coupled device (CCD) or a complementary metal 
oxide semiconductor (CMOS) imaging device. 
The use of a small laser diode 12, especially one with a 
short coherence length, allows for use of the probe without 
a fiber optic cable. For purposes of this disclosure, the term 
"short coherence length" is anything with a coherence length 
between 10 cm-100 cm. In one aspect, the laser diode may 
output a wavelength of between 700 and 900 nm ( e.g. 785 
nm), at a power of below 25 mW, and may have a diameter 
of 5.6 mm (e.g. L785P25, Thorlabs, NJ). A wavelength of 
700-900 nm ( e.g. 785 nm) may be used for measuring blood 
flow, and two laser diodes with different wavelengths may 
be used for measuring a different tissue parameter ( e.g. 
distance. In one aspect of the invention, the S-D distance 
may vary from Oto 20 mm, or more narrowly from 13 mm 
to 18 mm. Based on photon diffusion theory, NIR light 
35 penetration depth in tissues is approximately one half of the 
S-D distance. This is because light transport through tissue 
is diffuse rather than straightforward. Therefore, penetration 
depth of light and the ability to take measurements based 
thereon depend on the S-D separation distance (i.e. about 
40 halfofthe S-D separation). The range ofS-D separation that 
may be used depends on the arrangement of the laser diode 
12 and the imaging device 14, as well as the light intensity 
and imaging device sensitivity. In the present invention, 
typical S-D distances may be from 0 mm-20 mm. Therefore, 
45 the penetration depth may be from 0 mm-10 mm. 
A retainer 16 may be provided for maintaining relative 
position between the laser diode 12 and the bare imaging 
device 14. The retainer 16 may be in the form of a pad, a 
plate, a block, or a film, which may include one or more 
50 receivers for receiving the laser diode 12 and the bare 
imaging device 14. For example, the retainer 16 may com-
prise a foam pad with an aperture or retaining space for each 
of the laser diode 12 and the bare imaging device 14. In one 
aspect, a thin film may be provided (not pictured) to prevent 
55 the bare imaging sensor 22 and/or the bare imaging chip 20 
from being shorted by the turbid media M. 
With further reference to FIG. 2, one embodiment of the 
bare imaging device 14 is illustrated. The imaging device 14 
may include the bare imaging sensor 22 and the bare 
60 imaging chip 20, which may be located at the bottom of the 
bare imaging device 14, such as for being placed in contact 
with the surface of the tissue to be measured. The bare 
imaging chip 20 may operate as a plurality of flow detectors. 
For example, each window of7x7 pixels may act as a single 
65 detector. This may allow a single bare imaging chip 20 to 
include hundreds of detectors. The bare imaging chip 20 
may be connected and controlled by an external controller, 
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such as a computer, a laptop, or other mobile device. In one 
aspect, the connection may be through a Universal Serial 
Bus cable (not shown). 
One issue with a CCD or CMOS based contact measure-
ment is that some CCD or CMOS chips may accumulate 5 
heat. This accumulation of heat from a bare imaging sensor/ 
chip, which is directly contacted to the surface of target 
media, could cause discomfort to a subject or may interfere 
with probe efficacy. In order to spread the heat that may be 
generated by a CCD or CMOS chip, multiple small heat 10 
sinks 24 may be included. The heat sinks may be in the form 
of a plate or fin. The heat sinks 24 may be attached, such as 
by a thermal compound, to the integrated circuits of the 
imaging chip. For example, the heat sinks may be approxi-
mately 6x6 mm2 . A fan 26 may also be included for further 15 
enhancing heat dissipation. One or more additional heat 
sinks, such as a 40x40 mm heat sink, may be connected to 
the fan 26 to further assist in heat dissipation. 
In another aspect, the potential accumulation of heat may 
be addressed by the use of an imaging device 14 with a low 20 
power consumption. For example, a small CMOS sensor 
may be used, such as the MU9PM-MBRD, by Ximea, which 
has a typical power consumption of0.6 W. Another example 
of a CMOS chip is the NanEye by Awaiba, with a power 
consumption as low as 4.2 mW. With a small, low-power 25 
CMOS sensor, the size of the DSCF probe may be mini-
mized to 6x8 mm2 (e.g. using "L785P25" as a laser diode 
and "NanEye" as imaging device; S-D distance is set as 
minimal) and the generated heat may be significantly 
reduced. As a result, the new DSCF probe can work properly 30 
without using sinks/fans for heat dissipation. 
The laser diode 12 may be inserted into a socket ( e.g. 
S7060R, Thorlabs, NJ) and may be powered by a constant-
current driver ( e.g. LDC 205C, Thorlabs, NJ). The laser 
diode 12 may oscillate in a single transverse mode, and may 35 
support multiple longitudinal modes. In one aspect, the laser 
diode 12 would not be expected to exhibit a long coherence 
length. However, few mode lasers have complex correlation 
functions that are not well described by a single coherence 
length. To assess this, the laser diode 12 may be placed in a 40 
Michelson interferometer and operated under the same con-
ditions as in the DSCF probe 10 (constant 50 mA drive 
current with no active temperature stabilization). When this 
was done with the laser diode identified herein, high-
visibility (>0.8) fringes were observed at many path-length 45 
differences between O and 400 mm (limit oftest). Thus, the 
laser's coherence is entirely sufficient for the S-D separa-
tions described herein. 
One distinction between a CCD or CMOS based imaging 
device of the DSCF and the APD detection in DCS is the 50 
transition from measurements of slower temporal speckle 
fluctuations with sufficient signal-to-noise ratio (i.e. hun-
dreds of milliseconds for DCS probes) to faster spatial 
speckle fluctuations (i.e. a few milliseconds for the DSCF 
probe). To measure speckle fluctuations, lasers with certain 55 
coherence length are needed. In general, the coherence 
length of a laser must be longer than the photon path length 
throughout the tissue, which is generally several time ( e.g. 
five times for muscles) longer than the distance between the 
source and the detector. For example, the maximal S-D 60 
distance for the DSCF may be approximately 20 mm, so a 
laser diode for a DSCF probe should have a coherence 
length of approximately 10 cm at least. 
In order to catch up with the slower temporal fluctuations 
(i.e. mathematically calculating the temporal autocorrelation 65 
function), DCS uses a laser with a coherence length longer 
than several meters (which has been experimentally deter-
8 
mined). The long coherence length requirement makes the 
laser required for DCS larger in dimension (so that it cannot 
be placed on the tissue directly) as well as expensive. The 
light from such long coherence length lasers must also be 
passed through an optical fiber. However, an optical fiber is 
rigid and lacks flexibility desired for a probe that may 
positionally manipulated easily. 
By contrast, DSCF measures fast spatial speckle fluctua-
tions within only about 5 ms, mathematically calculating 
where 0
5 
is the spatial standard deviation and ( 1) is the 
mean intensity in a 7x7 pixel window). Therefore, a laser 
diodes with a coherence length longer than tens of centime-
ters can be used for DSCF. Most laser diodes meet this 
specification. For purposes of this disclosure, a laser diode 
for use with a DSCF probe need only have a low coherence 
length (i.e. greater than 10 cm, but less than 100 cm). And 
laser diodes are significantly smaller in size than a laser with 
long coherence length required for a DCS probe. Therefore, 
the laser diode can be placed directly on the tissue of a 
subject without the use of any optical fibers. Another advan-
tage to the use of a bare CCD or CMOS as compared to a 
larger APD is the elimination of fiber coupling. The size of 
an APD is large and cannot be placed directly on the tissue. 
So the APD has to be connected to an optical fiber as well. 
The bare CCD or CMOS does not require any such optical 
fiber. This provides flexibility in the DSCF probe that is not 
available in a DCS probe, while still allowing for accuracy 
of measurements. 
In order to calibrate/validate the DSCF probe 10, concur-
rent flow measurements on liquid tissue phantoms against a 
noncontact CCD-based diffuse speckle contrast probe and a 
standard contact DCS probe were conducted. The liquid 
tissue phantom comprised distilled water, India ink, and 
Intralipid, which has been commonly used for the calibra-
tion of flow measurement techniques. India ink is used to 
manipulate the absorption coefficient µa while Intralipid 
provides particle Brownian motion (flow) and control of the 
reduced scattering coefficient µ;. The absorption coefficient 
was set to µa =0.03 cm- 1 and µ)=8 cm- 1 at 785 nm to mimic 
the property of biological tissues. Flow variations of Intra-
lipid particles were created by changing the phantom tem-
perature. The temperature of the phantom was initially set up 
to 70° C. by an immersed heater (CH103, Ovente, Calif.), 
and then decreased naturally until reaching the room tem-
perature of -22° C. A thermometer sensor (Physitemp, NJ) 
was placed inside the liquid tissue phantom for temperature 
measurements. 
An example of a representative schematic for a phantom 
experiment for testing the validity and accuracy of the DSCF 
is shown in FIG. 3. This phantom experiment was designed 
to compare the results obtained concurrently from the con-
tact measurements using two different contact probes (i.e., 
DSCF and DCS) and a noncontact measurement using 
another CCD camera with optical lenses (e.g., FL3-FW-
20S4M-C, Point Grey, BC, Canada). As shown in FIG. 3, a 
dual contact probe element 30 includes both the bare imag-
ing device 14 of the DSCF (in this instance a CCD), as well 
as a detector fiber 32 to an APD (not illustrated) to utilize 
DCS. In addition, a noncontact CCD camera 36 was utilized, 
which included multiple lenses 38 for focusing and manipu-
lating light source. 
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Due to the use of DCS for validation, a long-coherence 
length DCS laser 34 (e.g. DL785-100, CrystaLaser, NV; 
wavelength: 785 run, coherence length: >5 m, power: 100 
mW, dimensions: 135x36x30 mm3 , price: >$7K) was uti-
lized. The DCS laser 34 delivered NIR light to the liquid 5 
tissue phantom P via a customized 1 x2 fiber-based beam 
splitter ( e.g. Fiberoptic Systems, CA). A single-mode detec-
tor fiber (e.g. SM800-5.6-125, Fibercore, CA) connected to 
a 4-channel APD module (e.g. SPCM-AQ4C, PerkinElmer, 
CA; dimensions: 150x130x34 mm3 , price: >$11K) and a 10 
4-channel autocorrelation board (e.g., Flex0lLQ-05, Zhu, 
Jixiang, NJ; price: -$13K) was used to collect the diffused 
light for the contact DCS measurement as a gold standard for 
comparisons. An identical S-D distance Y was used for all 
three probes for consistency, and in this instance, an S-D 15 
distance of 15 mm was used in all three probes. The 
placement of the bare imaging device 14 (with its CCD 
detector 46, comprising a set of7x7 pixels of the CCD) and 
the DCS detector fiber 32, each with respect to the long 
coherence length DCS laser 34 for the contact probes, can be 20 
seen in FIG. 4. During the calibration/validation procedure, 
thirty data points (DCS) or frames (CCDs) were concur-
rently collected within 15 seconds (i.e., 2 Hz sampling rate) 
by the three probes at each of three different temperatures 
(65° C., 45° C., and 25° C.). The two CCDs worked in 25 
parallel with the same exposure time of 5 ms. Room light 
was turned off during these measurements. 
For standard DCS data analysis, flow index was extracted 
by fitting the autocorrelation curve whose decay rate 
depended on the motion of moving Intralipid particles. For 30 
DSCF data analysis, as described above, the spatial speckle 
contrast (K) over a selected window of 7x7 pixels was 
determined by calculating the ratio of standard deviation ( a) 
and mean (µ) over these 49 pixels; i.e., K=a/µ. Flow-
induced speckle fluctuation resulted in the reduction of laser 35 
speckle contrast in space for a given exposure time. Flow 
index was extracted via a nonlinear relationship between the 
Kand flow index under semi-infinite geometry. To increase 
the signal-to-noise ratio (SNR) of flow detection, a 3x3 
adjacent pixel window array ( covering an area of - 78 40 
µmx78 µm) with nine values of K were averaged represent-
ing one DSCF detector. The detector center was chosen at 15 
mm away from the laser source, allowing a penetration 
depth of -8 mm. Relative flow changes were calculated by 
normalizing flow data at all measurement steps (i.e., 65° C., 45 
45° C., and 25° C.) to the averaged flow index (assigning 
100%) at the last step (25° C.). 
Bland-Altman plot analysis was used to determine the 
agreement between different measurements and Mann-
Whitney u-test was used to test the systematic difference in 50 
mean values between the measurements (i.e., the fixed bias). 
FIGS. Sa-Sc show Bland-Altman plots for the comparisons 
between the two of three flow measurements by the three 
optical probes. Specifically, FIG. Sa illustrates a comparison 
of the contact DSCF probe and the non-contact CCD probe. 55 
FIG. Sb illustrates a comparison of the contact DSCF probe 
and the contact DCS probe. FIG. Sc illustrates a comparison 
of the non-contact CCD probe and the contact DCS probe. 
The y-axis shows the difference between the two paired 
measurements (A-B) and the x-axis shows the mean value of 60 
these measurements (A+B)/2. The horizontal solid line 
represents the mean value of (A-B) and horizontal dashed 
lines represent the mean values of (A-B)±l.96xstandard 
deviation of (A-B). For a good agreement between two 
measurements, approximately 95% of the differences are 65 
expected to be less than 1.96 standard deviation. Good limits 
of agreement among these measurements (95.6% in FIG. Sa, 
10 
97.8% in FIG. Sb, and 100.0% in FIG. Sc) were observed. 
This experiment demonstrated that the contact and noncon-
tact CCD-based diffuse speckle contrast measurements of 
flow changes generated highly consistent results (FIG. Sa), 
each of which also significantly agreed with the standard 
contact DCS measurement results (FIG. Sb and FIG. Sc). 
A second phantom experiment, a representative schematic 
for which is shown in FIG. 6, was designed to compare the 
results obtained by the short coherence length laser diode 12 
for DSCF and the long-coherence laser 34 for standard DCS. 
Therein, a dual contact probe 30' includes the bare imaging 
device 14 (again, in this case a CCD) of the DSCF probe 10 
and the corresponding short coherence length laser diode 12. 
In addition, the dual contact probe 30' includes the long 
coherence length DCS laser 34 for use with the DCS 
detector fiber 32, which is connected to an APD (not 
illustrated) to utilize DCS. The dual contact probe 30' was 
placed in contact with a surface of the liquid tissue phantom 
P. 
As illustrated in FIG. 7, the short coherence length laser 
diode 12 was placed at an identical S-D distance from the 
CCD detector 46 of the bare imaging device 14 as the long 
coherence length DCS laser was placed from the DCS 
detector fiber 32. This identical S-D distance is shown as Y' 
in FIG. 7. For the purposes of this second phantom experi-
ment, Y' was set to 15 mm. 
Experimental protocols, data collection, and data analyses 
were similar to those described above. For each measure-
ment at certain temperature (i.e. 65° C., 45° C., and 25° C.), 
two lasers were turned on alternatively and thirty data points 
were collected in parallel by the DSCF and DCS detectors 
at the sampling rate of 2 Hz. 
FIGS. Sa-Sc show the Bland-Altman analysis between the 
two of three flow measurements by different compositions of 
sources and detectors. Specifically, FIG. Sa illustrates a 
comparison of the short coherence length laser diode 12 
used with the DSCF probe and the long coherence length 
laser 34 used with the DSCF probe (i.e. the bare CCD 14). 
FIG. Sb illustrates a comparison of the short coherence 
length laser diode 12 used with the DCS detector fiber 32 
and the long coherence length laser 34 used with the DCS 
detector fiber 32. FIG. Sc illustrates a comparison of the 
short coherence length laser diode 12 used with the DSCF 
probe (i.e. the bare imaging device 14 using a CCD) and the 
long coherence length laser 34 used with the DCS detector 
fiber 32. Good limits of agreement among these measure-
ments (94.4% in FIG. Sa, 94.4% in FIG. Sb and 96.7% in 
FIG. Sc) were observed with no significant bias (p>0.05 in 
Mann-Whitney u-tests ). This experiment demonstrated that 
these two lasers (i.e., short coherence length laser diode 12 
and long coherence length laser 34) generated consistent 
results for the measurements of flow changes with both the 
DSCF detector (FIG. Sa) and the standard DCS detector 
(FIG. Sb). The consistency between the DSCF probe (i.e., 
short coherence length laser diode 12 used with bare CCD 
14) and standard DCS probe (i.e., long coherence length 
laser 34 used with DCS detector fiber 32 and APD) mea-
surements of flow changes (FIG. Sc) validated the new 
device and methodology (i.e., use of the DSCF probe). 
Further validation measurements in human tissues have 
also been conducted. A healthy subject was asked to sit and 
extend his right forearm on a table. With reference to FIG. 
9, a dual contact probe 30", including the bare imaging 
device 14 (again using a CCD) of the DSCF probe as well 
as the DCS detector fiber 32 and APD of a standard DCS 
probe was utilized on the right forearm of the subject in 
order to measure concurrent BF measurements. The dual 
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contact probe 30" included a foam pad for receiving the bare 
imaging device 14, the DCS detector fiber 32, and the short 
coherence length laser diode 12, as shown in FIG. 10. As 
shown in FIG. 9, the dual contact probe 30" and an arterial 
cuff were attached to the arm of the subject. An arterial 5 
cuff-occlusion (230 mmHg) paradigm was applied on sub-
ject's right upper arm to induce significant BF changes in the 
right forearm. The occlusion protocol included a 3-minute 
baseline, a 3-minute cuff inflation, and a 3-minute recovery 
period following the cuff deflation. The sampling rates for 10 
both DSCF and DCS measurements were set as 1 Hz (lower 
than the 2 Hz in tissue phantom experiments) in order to 
improve SNRs of BF measurements in human tissues. Data 
analyses were similar to those described in the tissue phan-
tom experiments, and are illustrated in FIG. lla and 1 lb. 15 
Relative blood flow (rBF) changes were normalized to the 
mean value of baseline BF data before the cuff-occlusion 
(assigning 100%). 
FIG. lla shows the time course rBF data measured 
concurrently by the DSCF and DCS probes in the forearm 20 
before, during, and after the occlusion. The relatively lower 
limit of agreement observed in the forearm measurement 
(92.8% in FIG. llb), as compared to those in the phantom 
tests, was likely due to heterogeneous reactive responses of 
blood flow in different regions/volumes of the forearm tissue 25 
measured by different probes. No significant bias was 
observed between the two measurements (p>0.05 in the 
Mann-Whitney u-test). 
Similar validation protocols were followed with respect to 
the use of the imaging device 14 using the smaller, low- 30 
powered CMOS device as described above, for reduced heat 
generation. Illustrations of the validation experiment of the 
CMOS based imaging device 14 are illustrated in FIGS. 12 
and 13a-13b. Therein, a healthy volunteer was asked to sit 
and extend his forearm on a table, as is illustrated in FIG. 9. 35 
A dual probe 30"' included the CMOS imaging device 14' 
and a standard DCS probe, both confined by a foam pad and 
taped on the forearm's surface for concurrent blood flow 
measurements. The S-D distance of 15 mm was used for 
both DSCF and DCS measurements (i.e. between both the 40 
laser diode 12 and CMOS imaging device 14' as well as 
between the DCS laser 34 and the detector fiber 32 to the 
APD). The CMOS imaging device 14' and the detector fiber 
32 to the APD for use with DCS were place 60 mm apart. 
An arterial cuff-occlusion (230 mmHg) was applied on the 45 
upper arm to induce blood flow changes in the forearm. The 
relative blood flow (rBF) data before, during, and after the 
arterial occlusion are shown in FIG. 13a. As expected, a 
significant correlation (R2=0.89, p<l0-5 ) and an excellent 
linear relationship (slope: 1.07%, intercept: 12.00%) 50 
between the DSCF and DCS measurements of rBF were 
observed (FIG. 13b). Bland-Altman analysis showed no 
significant bias with a good limit of agreement (93.9%), 
which is similar to our previous result (92.8%). 
In order to evaluate the ability of the DSCF probe 10 to 55 
make transcranial measurements through the superficial 
tissues of a head ( e.g., infant skull), comparison measure-
ments were conducted using the DSCF probe 10 and a 
standard DCS probe in a head-simulating phantom (FIG. 
14). A realistic human infant skull (31 weeks of age) was 60 
kept inverted and filled with a turbid liquid solution mim-
icking the brain tissue. The homogenous liquid phantom 
comprised distilled water, India ink, and Intralipid, which 
has been extensively used for optical instrument calibra-
tions. India ink is used to manipulate the absorption coef- 65 
ficient µa while Intralipid provides particle Brownian motion 
(flow) and control of the scattering coefficient µ;. Flow 
12 
variations of Intralipid particles were created by changing 
the phantom temperature, which was monitored by a ther-
mocouple sensor (Physitemp) placed inside the phantom. 
The temperature was initially set up to -50° C. by an 
immersed heater, and then decreased naturally until it 
reached -30° C. 
The data collected by the DSCF probe 10 (placed on the 
bottom of the inverted skull, FIG. 14) with two S-D dis-
tances (10 and 15 mm) at 8 different temperatures were 
analyzed using layer algorithms to correct partial volume 
artifacts from the skull (FIG. 15a) and compared to the 
conventional semi-infinite solutions with the S-D distances 
of 15 mm (FIG. 15b) and 10 mm (FIG. 15c), respectively. 
The layer algorithms are described in the following publi-
cations, the disclosures of which are incorporated herein by 
reference: 1) Shang Y, Li T, Chen L, Lin Y, Toborek Mand 
Yu G, Extraction of diffuse correlation spectroscopy flow 
index by integration of Nth-order linear model with Monte 
Carlo simulation, Applied Physics Letters. 2014, 104: 
193703; and 2) Shang Y and Yu G, A Nth-order linear 
algorithm for extracting diffuse correlation spectroscopy 
blood flow indices in heterogeneous tissues, Applied Physics 
Letters, 2014, 105:133702. The semi-infinite solutions are 
described in the following publications, the disclosures of 
which are incorporated herein by reference: 1) Shang Y, 
Cheng R, Dong L, Ryan S J, Saha S P and Yu G, Cerebral 
monitoring during carotid endarterectomy using near-infra-
red diffuse optical spectroscopies and electroencephalo-
gram, Phys Med Biol., 2011; 56:3015-3032; 2) Cheng R, 
Shang Y, Hayes D, Saha S P and Yu G, Noninvasive optical 
evaluation of spontaneous low frequency oscillations in 
cerebral hemodynamics, Neuroimage, 2012; 62:1445-1454; 
and 3) Cheng R, Shang Y, Wang SQ, Evans J M, Rayapati 
A, Randall D C and Yu G, Near-infrared diffuse optical 
monitoring of cerebral blood flow and oxygenation for the 
prediction of vasovagal syncope, J Biomed Opt., 2014; 19. 
A fusiform shell matching the skull dimensions was used 
for Monte Carlo simulations required for the layer algo-
rithms. The li.rBF values were then compared to the "true" 
flow variations measured by the DCS probe (placed directly 
on the surface of Intralipid solution through the foramen 
magnum, FIG. 14) with a single S-D distance of 8 mm. A 
better correlation between DSCF and DCS measurements 
was observed with the layer algorithms (FIG. 15a) com-
pared to the semi-infinite solutions without the correction of 
partial volume artifacts (FIG. 15b and FIG. 15c). As 
expected, partial volume artifacts from the skull had less 
influence on the measurements with larger S-D distance 
(FIG. 15b) than those with shorter distance (FIG. 15c). 
Bland-Altman analysis showed no significant bias with good 
limits of agreement for the layer algorithms (100%) and 
semi-infinite solutions at larger-distance (100%) and at 
shorter distance (87.5%). 
These results demonstrate high consistency between 
DSCF and DCS measurements of flow changes in the human 
tissue and infant-head-simulating phantoms. Importantly, 
DSCF flow measurements with multiple S-D distances (such 
as may be provided by a high-resolution CMOS pixel array) 
can be performed transcranially through the superficial 
infant skull and the partial volume artifacts from the top 
skull layer can be significantly reduced using the linear layer 
algorithms noted above. 
In contrast to noncontact CCD-based diffuse speckle 
contrast probes, the DSCF probe 10 allows for contact 
measurements of tissue BF variations, which can avoid 
potential motion artifacts and ambient light influence 
occurred in noncontact measurements. The major difference 
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between the noncontact CCD detection scheme and contact 
DSCF is the way to use CCD: the noncontact CCD detection 
scheme uses a CCD camera with lenses without touching the 
tissue whereas the contact DSCF probe 10 uses a bare CCD 
chip 20 in contact with the tissue surface. The noncontact 5 
CCD probe with a zoom lens provides the flexibility to 
change the magnification and resolution of imaging, but 
should not affect the detection of BF. Therefore, the prin-
ciples of noncontact CCD detection scheme and contact 
DSCF are essentially the same. The consistent results from 10 
our noncontact and contact CCD measurements of flow 
variations (FIG. Sa) support the commonality of these 
principles. 
Compared to conventional contact DCS probes which 
commonly use rigid optical fibers for light delivery and 15 
detection, the compact DSCF probe 10 can be placed 
directly on the tissue surface without using any optical fiber. 
The connections between the DSCF probe and a control unit 
(including a driver for the laser diode and a laptop for CCD 
operation) are all electrical wires/cables, which provide the 20 
flexibility for probe installation and offer the potential for 
remotely longitudinal monitoring of tissue BF variations 
through wireless data transferring. Moreover, using an inex-
pensive laser diode 12 with a short coherence length and 
bare imaging chip 20 (such as a CCD or CMOS), the cost of 25 
a DSCF probe 10 significantly less than a conventional 
4-charmel DCS flowmeter that uses a long-coherence laser, 
a 4-channel APD module, and a 4-channel autocorrelator 
board (e.g. approximately $1,300 as compared to approxi-
mately $23,000). The cost-efficiency can be improved even 30 
more when conducting tomographic measurements as the 
single imaging chip ofDSCF probe provides multiple detec-
tors for image reconstruction. 
In a further aspect of the invention, the DSCF technique 
can be extended to the use of multiple wavelengths to 35 
simultaneously measure multiple parameters, such as cere-
bral hemodynamic and metabolic parameters. These may 
include blood flow, blood oxygenation, oxygenation varia-
tions, StO2 , and CMRO2 , in deep tissues. This may be 
accomplished by using two or more laser diodes at different 40 
wavelengths. This results in a low-cost compact diffuse 
speckle contrast flow-oximeter (DSCFO). The principles of 
the DSCFO are similar to the DSCF, as indicated below. 
The DSCFO may comprise a DSCFO probe 110 including 
at least two laser diodes 112a and 112b, and a bare imaging 45 
device 114, as illustrated in FIG. 16. The laser diodes may 
output light at different wavelengths. The wavelengths may 
correspond to one or more particular parameters to be 
measured. For example, a first laser diode 112a may output 
a wavelength of 690 nm, at a power of30 mW, and may have 50 
a diameter of 5.6 mm (e.g. HL6738MG, Thorlabs, NJ), 
while the second laser diode 112b may output a wavelength 
of 830 nm, at a power of 50 mW, and may have a diameter 
of 5.6 mm (e.g. HL8338MG, Thorlabs, NJ). The use of two 
laser diodes at such wavelengths may form a dual-wave- 55 
length flow-oximeter, which may maximize the sensitivity 
of StO2 measurements. This is due to the different optical 
absorption characteristics of oxy-hemoglobin (HbO2 ) vs. 
deoxy-hemoglobin (Hb ). Other combinations of wave-
lengths may be used, such as 785 nm and 854 nm for 60 
measuring both blood flow and oxygenation. 
The bare imaging device 114 may comprise a 2-dimen-
sional array, such as a CCD or CMOS. In one aspect, the 
bare imaging device 114 comprises a CMOS chip (e.g. 
MU9PM-MBRD, Ximea), which may offer a 2592x1944 65 
pixel array and may allow for an effective frame rate of 14 
images per second. A 7x7 region of sensor pixels is the 
14 
minimum requirement for conducting an effective BF mea-
surement. Utilizing various subsets of pixels/detectors in the 
active-pixel array, the DSCFO probe 110 can take up to 
-1,439,670 measurements per second. The high sampling 
rate allows several possible optimal modes to operate. For 
example, measurement accuracy can be increased by utiliz-
ing averaging data from multiple pixel/detector measure-
ments, thereby reducing the impact of stochastic variation 
and sensor noise. Rapid multiple-charmel measurements at 
different S-D distances enable the quantification of tissue 
hemodynamic heterogeneity at varying regions/depths of the 
head and reduction of partial volume artifacts from the scalp 
and skull. And pulsed operation can be employed in a 
manner that allows measurements to be taken intermittently 
( e.g., using a ½4 duty cycle), thus significantly reducing 
power consumption and heat production. Other small-size, 
low-power, and/or high-sensitive CMOS sensors may be 
utilized in the DSCFO probe, such as NanEye (AWAIBA, 
Germany) or Spy Camera (Adafruit Industries, New York) to 
further reduce the probe size and heat production and to 
increase the detection sensitivity/depth. 
The S-D distances may range between a first distance Dl 
and a second distance D2. These first and second distances 
Dl, D2 may be characterized as the distances between a 
given laser diode 112a, 112b and a given detector 146a, 
146b of the bare imaging device 114. As noted above, these 
detectors 146a, 146b may comprise a given 7x7 pixel region 
of the CMOS chip. In the illustrated embodiment of FIG. 16, 
the S-D distances may be 10 mm and 15 mm, respectively. 
S-D distances such as these allow measurements to be taken 
at sufficient depths (i.e. approximately half of the S-D 
distance, or 5-7.5 mm with the illustrated S-D distances) to 
penetrate the superficial layers of an infant's frontal scalp 
and skull. Moreover, multiple S-D distance measurements 
by the DSCFO probe allows for the reduction of partial 
volume artifacts from the top layer tissues using the linear 
layer algorithms noted above. 
By alternatively measuring relative changes in intensities 
of given detectors at the two wavelengths, relative changes 
in tissue absorption coefficients li.µjA) can be extracted 
based on a dual-wavelength NIRS method, assuming that 
the tissue scattering coefficient µ)(A) is kuown from the 
literature. This method is described in the following publi-
cation, the disclosure of which is incorporated herein by 
reference: Shang Y, Zhao, Y. Cheng, Y Dong L, Irwin D, Yu 
G, Portable optical tissue flow oximeter based on diffuse 
correlation spectroscopy, Optics Letters, 34(22), 3556-3558 
(2009). Concentration changes of li.[HbO2 ] and li.[Hb] can 
be determined from the measured li.µjA) at the two wave-
lengths and li.StO2 (%) can be calculated from the ratio of 
li.[HbO2 ]/([HbO2 ]+[Hb ]). 
By alternatively measuring intensities of given detectors 
at the two wavelengths and at multiple different S-D dis-
tances, tissue absorption coefficients µjA) can be extracted 
based on a spatially-resolved (multiple S-D distances) NIRS 
method, assuming that the cerebral tissue scattering coeffi-
cient µ)(A) is kuown from the literature. This method is 
described in the following publications, the disclosures of 
which are incorporated herein by reference: 1) Cheng R, 
Shang Y, Hayes D, Saha S P and Yu G, Noninvasive optical 
evaluation of spontaneous low frequency oscillations in 
cerebral hemodynamics. Neuroimage, 2012; 62:1445-1454; 
and 2) Liu H, Boas DA, Zhang Y, Yodh AG and Chance B, 
Determination of optical properties and blood oxygenation 
in tissue using continuous NIR light, Phys Med Biol., 1995; 
40:1983-93. Concentrations of [HbO2 ] and [Hb] can be 
US 10,842,422 B2 
15 
determined from the measured µjA) at the two wavelengths 
and StO2 (%) can be calculated from the ratio of [HbO2]/ 
([HbO2] +[Hb ]). 
Averaged blood flow index (BFI) at the two wavelengths 
represents a CBF value. The relative change in CMRO2 can 5 
be calculated based on Fick's law, rCMRO2=rCBFx(l-
StO2)/(l-StO26ase), where StO26ase is the baseline StO2 
before physiological changes. This method is described in 
the following publications, the disclosures of which are 
incorporated herein by reference: 1) Shang Y, Zhao Y, Cheng 1 o 
R, Dong L, Irwin D and Yu G. Portable optical tissue flow 
oximeter based on diffuse correlation spectroscopy, Opt 
Lett., 2009; 34:3556-3558; 2) Shang Y, Cheng R, Dong L, 
Ryan S J, Saha S P and Yu G. Cerebral monitoring during 
carotid endarterectomy using near-infrared diffuse optical 15 
spectroscopies and electroencephalogram, Phys Med Biol., 
2011; 56:3015-3032; 3) Cheng R, Shang Y, Hayes D, Saha 
S P and Yu G. Noninvasive optical evaluation of spontane-
ous low frequency oscillations in cerebral hemodynamics, 
Neuroimage, 2012; 62:1445-1454; 4) Gurley K, Shang Y 20 
and Yu G. Noninvasive optical quantification of absolute 
blood flow, blood oxygenation, and oxygen consumption rate 
in exercising skeletal muscle, J Biomed Opt., 2012; 
17:075010; 5) Shang Y, Li T, Chen L, Lin Y, Toborek Mand 
Yu G. Extraction of diffuse correlation spectroscopy flow 25 
index by integration of Nth-order linear model with Monte 
Carlo simulation, Applied Physics Letters, 2014; 104: 
193703; 6) Shang Y and Yu G. A Nth-order linear algorithm 
for extracting diffuse correlation spectroscopy blood flow 
indices in heterogeneous tissues, Applied Physics Letters, 30 
2014; 105 133702; 7) Cheng R, Shang Y, Wang SQ, Evans 
J M, Rayapati A, Randall D C and Yu G. Near-infrared 
diffuse optical monitoring of cerebral blood flow and oxy-
genation for the prediction of vasovagal syncope, J Biomed 
Opt. 2014; 19; 8) Shang Y, Chen L, Toborek Mand Yu G. 35 
Diffuse optical monitoring of repeated cerebral ischemia in 
mice. Opt Express. 2011; 19:20301-20315; 9) Chen L, 
Shang Y, Sipos K E, Saatman K E, Yu G and Toborek M. 
Novel experimental model for repeated forebrain ischemia-
reperfusion, Journal of experimental stroke and translational 40 
medicine, 2012; 5:1-10. 
As further illustrated in FIG. 16, the DSCFO probe may 
include a thermocouple 115. This may be used for evaluating 
the temperature of the surface of the tissue being evaluated. 
A retainer 116 may be provided for maintaining relative 45 
position between the laser diodes 112a, 112b and the bare 
imaging device 114. The retainer 116 may be in the form of 
16 
While the invention has been described with reference to 
specific examples, it will be understood that numerous 
variations, modifications and additional embodiments are 
possible, and all such variations, modifications, and embodi-
ments are to be regarded as being within the spirit and scope 
of the invention. Also, the drawings, while illustrating the 
inventive concepts, are not to scale, and should not be 
limited to any particular sizes or dimensions. Accordingly, it 
is intended that the present disclosure not be limited to the 
described embodiments, but that it has the full scope defined 
by the language of the following claims, and equivalents 
thereof. 
The invention claimed is: 
1. A probe for use in measuring a hemodynamic parameter 
deep within a tissue of a subject, said probe comprising: 
a light source comprising a laser diode for emitting 
near-infrared light into the tissue of the subject to 
provide point illumination; and 
a detector comprising a two-dimensional pixel array 
adapted to contact the tissue of the subject and receive 
diffuse light fluctuations reflected from the tissue to 
detect diffuse laser speckle contrast variations in the 
tissue for measurement of the hemodynamic parameter; 
wherein the light source and the detector are separated 
by a known source-detector ("S-D") distance that is 
approximately twice the desired penetration depth of 
the light source in a tissue, the detector being connected 
to a controller adapted to calculate a blood flow index 
from measured diffuse laser speckle contrast at the S-D 
distance by a diffusive model with a multiple scattering 
theory, and further wherein said probe includes no 
optical cable. 
2. The probe of claim 1, further including a retainer for 
retaining the light source laser diode and the detector at the 
known S-D distance fixed positions relative to each other. 
3. The probe of claim 2, wherein the retainer is selected 
from the group consisting of a block, a plate, a film or a foam 
pad. 
4. The probe of claim 1, wherein the laser diode produces 
a coherence length in human tissue larger than 10 cm and 1 
ill. 
5. The probe of claim 1, wherein the detector is adapted 
to receive the light reflected from the tissue without passing 
through any lenses prior to receiving the light. 
6. The probe of claim 1, wherein the known S-D distance 
is a distance of between O mm-20 mm. a pad, a plate, a block, or a film, which may include one or 
more receivers for receiving the laser diodes 112a, 112b and 
the bare imaging device 114. For example, the retainer 116 
may comprise a foam pad with an aperture or retaining space 
for each of the laser diodes 112a, 112b and the bare imaging 
device 114. 
7. The probe of claim 1, wherein the controller is remote 
50 from the source and detector. 
A 3D printer may be used to fabricate the probe. Each 
sensor element ( e.g. the CMOS chip and the thermocouple) 55 
and the laser diodes may be assembled with rubber-like 
photopolymers (e.g. PolyJet photopolymers) to form a soft 
surface that is suitable for long-term use. In one aspect, the 
soft surface may be adapted to conform to the surface 
curvature of a neuronal forehead. 60 
As can be seen in FIG. 17, in use, the DSCFO probe 110 
may be attached to a fixing element 118, such as medical 
tape, a bandage, or other adhesive strip, for retaining the 
probe in contact with the surface of the tissue. The DSCFO 
probe 110 may be connected to a controller, such as a 65 
computer, a laptop, or other mobile device, and power-
supply circuitry elements. 
8. The probe of claim 1, wherein the controller is con-
nected to the source and detector via electrical wires. 
9. The probe of claim 1, wherein the controller is con-
nected to the source and detector via electrical wires. 
10. The probe of claim 1, wherein the two-dimensional 
pixel array comprises a bare charge coupled device. 
11. The probe of claim 1, wherein the two-dimensional 
pixel array comprises a complementary metal oxide semi-
conductor. 
12. The probe of claim 1, further comprising an optical 
lens. 
13. The probe of claim 1, wherein the S-D distance is such 
that the probe can measure blood flow approximately up to 
10 mm below tissue surface. 
14. A method of measuring at least one hemodynamic 
parameter within a tissue of a subject, said method com-
prising: 
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placing the probe of claim 1 on surface tissue above the 
skull of the subject, wherein the two-dimensional pixel 
array of the detector is in contact with the tissue of the 
subject; 
emitting near-infrared light from the laser diode onto 5 
tissue of the subject, said near-infrared light not 
received through an optical cable; 
and 
measuring diffuse light from the tissue and calculating 
through the controller a blood flow index from mea- 10 
sured diffuse laser speckle contrast at the S-D distance 
by a diffusive model with a multiple scattering theory. 
15. The method of claim 14, further including the step of 
emitting light at a second wavelength from a second laser 
diode within the light source into the tissue, and wherein the 15 
measuring step comprises measuring reflected diffuse laser 
speckle contrast reflected from the tissue from the first laser 
diode and the second laser diode, alternatively. 
16. The method of claim 14, further including the step of 
attaching each of the light sources and the detector to a 20 
retainer in order to maintain the S-D distance. 
17. The method of claim 16, wherein the S-D fixed 
distance is between O mm and 20 mm. 
18. A probe for use in measuring at least one hemody-
namic parameter within a tissue of a subject, said probe 25 
comprising: 
a light source comprising a first laser diode adapted for 
emitting near-infrared light into the tissue of the subject 
at a first wavelength to provide a first point of illumi-
18 
nation and a second laser diode adapted for emitting a 
second point of illumination into the tissue of the 
subject at a second wavelength different from the first 
laser diode; 
a detector comprising a two-dimensional pixel array 
adapted to contact the tissue of the subject and receive 
diffuse light reflected from the tissue to detect diffuse 
laser speckle contrast variations in the tissue for mea-
surement of the hemodynamic parameter; and 
a retainer adapted to receive and maintain a known 
source-detector ("S-D") distance from each of the first 
laser diode and the second laser diode to the detector, 
said retainer including a contact surface adapted to 
contact the tissue of the subject; 
wherein the retainer is adapted to maintain the source and 
detector in contact with the tissue with no lens ther-
ebetween. 
19. The probe of claim 18, wherein the probe includes no 
optical cable. 
20. The probe of claim 18, wherein the two-dimensional 
pixel array comprises a charge coupled device. 
21. The probe of claim 18, wherein the two-dimensional 
pixel array comprises a bare complementary metal oxide 
semiconductor. 
22. The probe of claim 18, wherein the S-D distance is 
such that the probe can measure blood flow approximately 
up to 10 mm below tissue surface. 
* * * * * 
